medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility… Read more
medmix AG (MDMXF) - Total Assets
Latest total assets as of June 2025: $952.60 Million USD
Based on the latest financial reports, medmix AG (MDMXF) holds total assets worth $952.60 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
medmix AG - Total Assets Trend (2020–2024)
This chart illustrates how medmix AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
medmix AG - Asset Composition Analysis
Current Asset Composition (December 2024)
medmix AG's total assets of $952.60 Million consist of 27.4% current assets and 72.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.1% |
| Accounts Receivable | $43.80 Million | 4.6% |
| Inventory | $75.40 Million | 7.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $117.20 Million | 12.3% |
| Goodwill | $271.60 Million | 28.5% |
Asset Composition Trend (2020–2024)
This chart illustrates how medmix AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: medmix AG's current assets represent 27.4% of total assets in 2024, an increase from 19.5% in 2020.
- Cash Position: Cash and equivalents constituted 10.1% of total assets in 2024, up from 1.9% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 40.0% of total assets, a decrease from 53.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 28.5% of total assets.
medmix AG Competitors by Total Assets
Key competitors of medmix AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hanil Vacuum Co. Ltd
KQ:123840
|
Korea | ₩115.98 Billion |
|
Ivisionworks Co.,Ltd.
KQ:469750
|
Korea | ₩50.10 Billion |
|
Huayi Compressor Co Ltd
SHE:000404
|
China | CN¥15.16 Billion |
|
Shenyang Machine Tool Co Ltd
SHE:000410
|
China | CN¥9.63 Billion |
|
North Industries Group Red Arrow Co Ltd
SHE:000519
|
China | CN¥17.38 Billion |
|
Changchai Co Ltd
SHE:000570
|
China | CN¥5.30 Billion |
|
Jiangsu Youli Investment Holding Co Ltd
SHE:000584
|
China | CN¥3.49 Billion |
|
Baota Industry Co Ltd
SHE:000595
|
China | CN¥9.54 Billion |
medmix AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - medmix AG generates 0.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - medmix AG is currently not profitable relative to its asset base.
medmix AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.57 | 1.48 | 1.80 |
| Quick Ratio | 1.10 | 1.06 | 1.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $97.10 Million | $ 105.60 Million | $ 217.90 Million |
medmix AG - Advanced Valuation Insights
This section examines the relationship between medmix AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.37 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | -5.2% |
| Total Assets | $954.20 Million |
| Market Capitalization | $418.22 Million USD |
Valuation Analysis
Below Book Valuation: The market values medmix AG's assets below their book value (0.44 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: medmix AG's assets decreased by 5.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for medmix AG (2020–2024)
The table below shows the annual total assets of medmix AG from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $954.20 Million | -5.22% |
| 2023-12-31 | $1.01 Billion | -8.96% |
| 2022-12-31 | $1.11 Billion | +13.50% |
| 2021-12-31 | $974.40 Million | +23.03% |
| 2020-12-31 | $792.00 Million | -- |